OTPPB
ESPR

Ontario Teachers' Pension Plan Board’s Esperion Therapeutics ESPR Stock Holding History

Ontario Teachers' Pension Plan Board’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-24,832
Closed -$1.64M – 492
2017
Q4 		$1.64M Buy
+24,832
New +$1.34M 0.02% 431
2015
Q2 		– Sell
-32,678
Closed -$3.03M – 702
2015
Q1 		$3.03M Buy
+32,678
New +$2.11M 0.02% 440

Other funds holding ESPR

MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Ontario Teachers' Pension Plan Board's ESPR Position: Q1 2018 in Review

Ontario Teachers' Pension Plan Board sold out of Esperion Therapeutics (ESPR) in Q1 2018, closing a stake of 24,832 shares — an estimated $1.64M sold.

Ontario Teachers' Pension Plan Board first reported a position in ESPR in Q1 2015 and held it in 2 quarters. The position peaked at $3.03M in Q1 2015. 187 funds tracked by Wall St. Rank hold ESPR as of Q1 2018.

  • Ontario Teachers' Pension Plan Board reported no remaining Esperion Therapeutics position as of Q1 2018 after selling out during the quarter.
  • Ontario Teachers' Pension Plan Board sold 24,832 Esperion Therapeutics shares in Q1 2018, an estimated $1.64M.
  • Ontario Teachers' Pension Plan Board first reported a position in Esperion Therapeutics in Q1 2015 and held it in 2 quarters.
  • Ontario Teachers' Pension Plan Board's Esperion Therapeutics position peaked at $3.03M in Q1 2015.
  • 187 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q1 2018.

Based on Ontario Teachers' Pension Plan Board's 13F filing for Q1 2018, filed 11 May 2018.